Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

FDA Approved Products | Know the Drugs Behind the Job | Formulate

Home
Products

FDA Approved Products

6,363 products linked to open jobs. See lifecycle stage, competitive pressure, and patent timelines before you apply.

Search drug products

Type:All Branded (NDA+BLA)NDA BLA ANDA

Lifecycle:Growth Peak LOE Approaching Post-LOE Launch

Sort:Hiring Activity↓Competitive Pressure Approval Date Name

AZULFIDINE EN-TABS

LOE Approaching

ORAL · TABLET, DELAYED RELEASE

← PreviousPage 92 of 266Next →

AZULFIDINE EN-TABS

sulfasalazine

LOE Approaching

Pfizer

ORAL · TABLET

2000

NDA

30/100

sulfamethoxazole; trimethoprim

LOE Approaching

INJECTION · INJECTABLE

BACTRIM PEDIATRIC

sulfamethoxazole; trimethoprim

LOE Approaching

ORAL · SUSPENSION

LOE Approaching

NASAL · OINTMENT

LOE Approaching

TOPICAL · OINTMENT

LOE Approaching

TOPICAL · CREAM

LOE Approaching

INJECTION · INJECTABLE

Sunburnswind burned+1

cefpodoxime proxetil

LOE Approaching

ORAL · FOR SUSPENSION

development of drug-resistant bacteriamaintain the effectiveness of cefpodoxime proxetil+4

cefpodoxime proxetil

LOE Approaching

development of drug-resistant bacteriamaintain the effectiveness of cefpodoxime proxetil+4

LOE Approaching

INTRAVENOUS · SOLUTION

sodium bicarbonate; tartaric acid

LOE Approaching

ORAL · GRANULE, EFFERVESCENT

insulin glargine

Eli Lilly and Company

SUBCUTANEOUS · SOLUTION

delafloxacin meglumine

INTRAVENOUS · POWDER

skin structure infections (ABSSSI) caused by the following susceptible microorganisms: Staphylococcus aureus (including methicillin-resistant [MRSA]methicillin-susceptible [MSSA] isolates)+18

delafloxacin meglumine

skin structure infections (ABSSSI) caused by the following susceptible microorganisms: Staphylococcus aureus (including methicillin-resistant [MRSA]methicillin-susceptible [MSSA] isolates)+18

cerivastatin sodium

LOE Approaching

BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN

LOE Approaching

deathmyocardial infarction (MI) in patients with chronic coronary artery disease+8

LOE Approaching

INHALATION · AEROSOL, METERED

LOE Approaching

NASAL · AEROSOL, METERED

recurrence of nasal polyps following surgical removal

INTRAVENOUS · SOLUTION

LOE Approaching

Acrotech Biopharma

INTRAVENOUS · POWDER

bendamustine hydrochloride

Eagle Pharmaceuticals

INTRAVENOUS · SOLUTION

diphenhydramine hydrochloride

LOE Approaching

Johnson & Johnson

INJECTION · INJECTABLE